Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection
Our study suggested that a flat-dosing strategy of rifapentine was potentially safe and effective for latent tuberculosis infection treatment in Chinese children aged 1 to 10 years old.
Authors
- Shuihua Lu (ORCID: https://orcid.org/0000-0002-2625-7686)
- Xiao Zhu (ORCID: https://orcid.org/0000-0003-3295-619X)
- Peize Zhang (ORCID: https://orcid.org/0000-0002-4023-0228)
- Wen Yao Mak (ORCID: https://orcid.org/0000-0002-8346-2934)
- Xiaoqiang Xiang (ORCID: https://orcid.org/0000-0002-8683-2603)
- Wei Li (ORCID: https://orcid.org/0000-0003-0142-6583)
- Hongzhou Lu (ORCID: https://orcid.org/0000-0002-8308-5534)
- Nuo Xu (ORCID: https://orcid.org/0009-0003-3543-663X)
- Weijian Liu (ORCID: https://orcid.org/0000-0002-2098-0515)
- He Tian (ORCID: https://orcid.org/0000-0001-8105-9773)
- Hongjuan Qin
Institutions
- Fudan University (CN)
- Southern University of Science and Technology (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1093/jac/dkaf029
- Citations
- 4
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 5.58